Clinicians and researchers teamed up to investigate how inappropriate proinflammatory mechanisms contribute to the pathogenesis of drug-refractory epilepsy.
In a continued effort to bring the readers of The Scientist the most engaging social media experience, we have examined our full lineup of Facebook niche pages and found that we could streamline some of our channels to provide clearer and more succinct coverage.
The scientific community bid farewell to researchers who furthered the fields of molecular biology, virology, sleep science, and immunology, among others.
The COVID-19 pandemic is still with us. Biomedical innovation has rallied to address that pressing concern while continuing to tackle broader research challenges.